VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 452 filers reported holding VANECK VECTORS ETF TR in Q1 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $9,637,000 | +16.7% | 329,118 | +6.4% | 0.06% | +7.0% |
Q3 2019 | $8,258,000 | +18.6% | 309,200 | +14.0% | 0.06% | +14.0% |
Q2 2019 | $6,963,000 | -3.9% | 271,216 | -16.1% | 0.05% | -9.1% |
Q1 2019 | $7,249,000 | +10.4% | 323,317 | +3.9% | 0.06% | -6.8% |
Q4 2018 | $6,564,000 | +81.8% | 311,184 | +59.6% | 0.06% | +96.7% |
Q3 2018 | $3,611,000 | -20.1% | 194,948 | -5.4% | 0.03% | -28.6% |
Q2 2018 | $4,518,000 | 0.0% | 206,081 | 0.0% | 0.04% | 0.0% |
Q1 2018 | $4,518,000 | +7.2% | 206,081 | +13.7% | 0.04% | +5.0% |
Q4 2017 | $4,213,000 | +43.6% | 181,302 | +41.9% | 0.04% | +25.0% |
Q3 2017 | $2,934,000 | +32.5% | 127,797 | +27.4% | 0.03% | +23.1% |
Q2 2017 | $2,214,000 | -9.7% | 100,300 | -6.7% | 0.03% | -16.1% |
Q1 2017 | $2,451,000 | +15.7% | 107,506 | +6.2% | 0.03% | +6.9% |
Q4 2016 | $2,118,000 | -36.8% | 101,270 | -20.2% | 0.03% | -42.0% |
Q3 2016 | $3,353,000 | -29.3% | 126,872 | -25.9% | 0.05% | -34.2% |
Q2 2016 | $4,744,000 | – | 171,192 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |